HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinji Yamada Selected Research

C-Type Lectins (C-Type Lectin)

3/2019The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.
11/2018Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin.
9/2018Epitope mapping of anti-mouse podoplanin monoclonal antibody PMab-1.
6/2018Epitope Mapping of Monoclonal Antibody PMab-48 Against Dog Podoplanin.
4/2018Epitope Mapping of Monoclonal Antibody PMab-52 Against Cat Podoplanin.
12/2017Epitope Mapping of Monoclonal Antibody PMab-38 Against Dog Podoplanin.
12/2017Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas.
6/2017ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
4/2017Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
4/2017LpMab-23: A Cancer-Specific Monoclonal Antibody Against Human Podoplanin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinji Yamada Research Topics

Disease

31Neoplasms (Cancer)
01/2022 - 02/2017
13Neoplasm Metastasis (Metastasis)
03/2019 - 02/2017
9Mouth Neoplasms (Oral Cancer)
09/2018 - 10/2017
7Lung Neoplasms (Lung Cancer)
01/2022 - 12/2017
6Infections
01/2020 - 06/2002
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2019 - 02/2017
5Glioblastoma (Glioblastoma Multiforme)
06/2019 - 08/2017
5Squamous Cell Carcinoma of Head and Neck
06/2019 - 10/2017
5Brain Neoplasms (Brain Tumor)
04/2018 - 02/2017
4Colorectal Neoplasms (Colorectal Cancer)
08/2019 - 08/2017
4Colonic Neoplasms (Colon Cancer)
08/2019 - 10/2017
4Melanoma (Melanoma, Malignant)
06/2019 - 12/2017
3Deltaretrovirus Infections (BLV Infection)
01/2022 - 01/2018
3Paratuberculosis (Johne's Disease)
01/2020 - 01/2018
3Stomach Neoplasms (Stomach Cancer)
08/2019 - 12/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2017
2Disease Progression
01/2022 - 01/2019
2Cardiac Arrhythmias (Arrythmia)
11/2020 - 06/2016
2Bacterial Infections (Bacterial Infection)
01/2020 - 01/2019
2Esophageal Neoplasms (Esophageal Cancer)
06/2018 - 12/2017
2Mesothelioma
04/2018 - 12/2017
2Breast Neoplasms (Breast Cancer)
12/2017 - 08/2017
2Tick Infestations
01/2009 - 08/2008
1Diarrhea
09/2022
1Kidney Neoplasms (Kidney Cancer)
01/2022
1Adenosquamous Carcinoma
01/2022
1Atrial Fibrillation
11/2020
1Coronary Vasospasm (Coronary Artery Vasospasm)
10/2019
1Spasm (Spasms)
10/2019
1Oligodendroglioma
06/2019
1Virus Diseases (Viral Diseases)
01/2019
1Glioma (Gliomas)
09/2018
1Intellectual Disability (Idiocy)
09/2018
1alpha-Thalassemia
09/2018
1Carcinoma (Carcinomatosis)
06/2018
1Ovarian Neoplasms (Ovarian Cancer)
06/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2017
1Inflammation (Inflammations)
09/2017
1Residual Neoplasm
06/2016
1Cognitive Dysfunction
06/2016

Drug/Important Bio-Agent (IBA)

22Monoclonal AntibodiesIBA
01/2022 - 02/2017
11C-Type Lectins (C-Type Lectin)IBA
03/2019 - 02/2017
8Immunoglobulin G (IgG)IBA
08/2019 - 02/2017
6Glycoproteins (Glycoprotein)IBA
09/2018 - 02/2017
6podocalyxinIBA
09/2018 - 08/2017
5AntibodiesIBA
06/2019 - 06/2002
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 09/2018
4Trastuzumab (Herceptin)FDA Link
08/2019 - 08/2017
4human ERBB2 proteinIBA
08/2019 - 08/2017
4Proteins (Proteins, Gene)FDA Link
09/2018 - 12/2008
3Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2018
3Dinoprostone (PGE2)FDA Link
01/2020 - 01/2018
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2020 - 01/2018
3EpitopesIBA
09/2018 - 12/2008
3LigandsIBA
03/2018 - 04/2017
3EnzymesIBA
12/2017 - 08/2017
3ImmunosorbentsIBA
12/2017 - 08/2017
2VaccinesIBA
09/2022 - 08/2008
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2022
2Threonine (L-Threonine)FDA Link
01/2022 - 01/2020
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2019 - 09/2018
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2018 - 12/2017
2Peptides (Polypeptides)IBA
07/2018 - 07/2018
2ErbB Receptors (EGF Receptor)IBA
07/2018 - 12/2017
2Complement System Proteins (Complement)IBA
02/2017 - 02/2017
1A-Form DNA (A-DNA)IBA
09/2022
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022
1Formaldehyde (Formol)FDA Link
01/2022
1ParaffinIBA
01/2022
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2021
1Pharmaceutical PreparationsIBA
11/2020
1blinatumomabIBA
04/2020
1tisagenlecleucelIBA
04/2020
1Chimeric Antigen ReceptorsIBA
04/2020
1IsosorbideFDA Link
10/2019
1Sulfates (Sulfates, Inorganic)IBA
10/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1ProstaglandinsIBA
01/2019
1Meloxicam (Mobic)FDA LinkGeneric
01/2019
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
01/2019
1B7-H1 AntigenIBA
01/2019
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2019
1Amino AcidsFDA Link
07/2018
1Protein Isoforms (Isoforms)IBA
07/2018
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
04/2018
1MucinsIBA
04/2018
1Interferon-gamma (Interferon, gamma)IBA
01/2018
1Blocking AntibodiesIBA
01/2018
1Tuberculin (PPD)IBA
01/2018
1SteroidsIBA
09/2017
1Polymethyl Methacrylate (Sol)IBA
06/2016

Therapy/Procedure

11Therapeutics
01/2022 - 06/2002
1Maze Procedure
11/2020
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2019
1Injections
10/2019
1Molecular Targeted Therapy
12/2017
1Transplantation
11/2017
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
06/2016